CytomX Therapeutics (CTMX) Shareholder's Equity Growth (1y) (2015 - 2026)
CytomX Therapeutics (CTMX) Shareholder's Equity Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
CytomX Therapeutics |
520.30 Mn |
173.59 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,177.27% |
| Dec 31, 2025 |
21,812.28% |
| Sep 30, 2025 |
557.91% |
| Jun 30, 2025 |
483.99% |
| Mar 31, 2025 |
179.07% |
| Dec 31, 2024 |
99.04% |
| Sep 30, 2024 |
54.23% |
| Jun 30, 2024 |
63.27% |
| Mar 31, 2024 |
63.43% |
| Dec 31, 2023 |
44.67% |
| Sep 30, 2023 |
36.38% |
| Jun 30, 2023 |
-55.90% |
| Mar 31, 2023 |
-191.31% |
| Dec 31, 2022 |
-18,582.14% |
| Sep 30, 2022 |
-364.66% |
| Jun 30, 2022 |
-193.85% |
| Mar 31, 2022 |
-136.87% |
| Dec 31, 2021 |
94.10% |
| Sep 30, 2021 |
-36.68% |
| Jun 30, 2021 |
-1.22% |
